Performance of first-trimester serum screening for trisomy 21 before and from 11 + 0 weeks of gestational age in the Netherlands

Prenatal Diagnosis

Volumn 30, Issue 9, 2010, Pages 906-908

  Kuc, S ^a,b   Koster, M P H ^a,b   Visser, G H A ^b   Schielen, P C J I ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Biomarkers; Down syndrome; First trimester screening; Free human chorionic gonadotrophin; Pregnancy associated plasma protein A

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; BLOOD SAMPLING; CROWN RUMP LENGTH; DOWN SYNDROME; FALSE POSITIVE RESULT; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MENSTRUAL CYCLE; NETHERLANDS; NUCHAL TRANSLUCENCY MEASUREMENT; PERFORMANCE MEASUREMENT SYSTEM; PRENATAL SCREENING; PRIORITY JOURNAL; TRISOMY 21;

BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DATABASE MANAGEMENT SYSTEMS; DOWN SYNDROME; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; GESTATIONAL AGE; HUMANS; NETHERLANDS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES;

EID: 77956166372     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2581     Document Type: Article

References (9)

1. Cuckle HS, van Lith JM. 1999. Appropriate biochemical parameters in first trimester screening for Down syndrome. Prenat Diagn 19(6): 505-512. (Pubitemid 29271812)
2. Driscoll DA, Morgan MA, Schulkin J. 2009. Screening for Down syndrome: Changing practice of obstetricians. Am J Obstet Gynecol 200(4): 459.e1-459.e9.
3. Ekelund CK, Jorgensen FS, Petersen OB, et al. 2008. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. BMJ 337: a2547.
4. Evans MI, Krantz DA, Terrence W, et al. 2007. Meta-analysis of first trimester Down syndrome screening studies: free β-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocol. Am J Obstet Gynecol 196(3): 198-205.
5. Kirkegaard I, Petersen OB, Uldbjerg N, et al. 2008. Improved performance of first trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks. Prenat Diagn 28(9): 839-844.
6. Malone FD, Canick JA, Ball RH, et al. 2005. First trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353(19): 2001-2011.
7. Palomaki GE, Lambert-Messerlian GM, Canick JA. 2007. A summary analysis of Down syndrome markers in the late first trimester. Adv Clin Chem 43: 177-210. Review.
8. Spencer K, Crossley JA, Aitken DA, et al. 2002. Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy. Ann Clin Biochem 39(6): 567-576.
9. Wortelboer EJ, Koster MP, Stoutenbeek P, et al. 2009. First trimester Down syndrome screening performance in the Dutch population; how to achieve further improvement? Prenat Diagn 29(6): 588-592.